Laboratory Corporation of America Holdings Company Profile (NYSE:LH)

About Laboratory Corporation of America Holdings (NYSE:LH)

Laboratory Corporation of America Holdings logoLaboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services - NEC
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:LH
  • CUSIP: 50540R40
  • Web: www.labcorp.com
Capitalization:
  • Market Cap: $16.49 billion
  • Outstanding Shares: 102,300,000
Average Prices:
  • 50 Day Moving Avg: $148.63
  • 200 Day Moving Avg: $141.88
  • 52 Week Range: $119.51 - $164.22
P/E:
  • Trailing P/E Ratio: 21.56
  • Foreward P/E Ratio: 15.82
  • P/E Growth: 1.95
Sales & Book Value:
  • Annual Revenue: $9.55 billion
  • Price / Sales: 1.73
  • Book Value: $55.08 per share
  • Price / Book: 2.93
Profitability:
  • EBIDTA: $1.85 billion
  • Net Margins: 7.76%
  • Return on Equity: 16.99%
  • Return on Assets: 6.51%
Debt:
  • Debt-to-Equity Ratio: 0.96%
  • Current Ratio: 1.42%
  • Quick Ratio: 1.30%
Misc:
  • Average Volume: 706,551 shs.
  • Beta: 0.93
  • Short Ratio: 3.29
 
Frequently Asked Questions for Laboratory Corporation of America Holdings (NYSE:LH)

What is Laboratory Corporation of America Holdings' stock symbol?

Laboratory Corporation of America Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corporation of America Holdings' earnings last quarter?

Laboratory Corporation of America Holdings (NYSE:LH) issued its earnings results on Wednesday, July, 26th. The company reported $2.47 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.40 by $0.07. The company earned $2.50 billion during the quarter, compared to analyst estimates of $2.47 billion. Laboratory Corporation of America Holdings had a return on equity of 16.99% and a net margin of 7.76%. The firm's quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the business posted $2.36 EPS. View Laboratory Corporation of America Holdings' Earnings History.

What guidance has Laboratory Corporation of America Holdings issued on next quarter's earnings?

Laboratory Corporation of America Holdings issued an update on its FY17 earnings guidance on Wednesday, July, 26th. The company provided EPS guidance of $9.30-9.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.43. The company issued revenue guidance of +5.0-6.5% to ~9.91-10.05 billion, compared to the consensus revenue estimate of $9.86 billion.

Where is Laboratory Corporation of America Holdings' stock going? Where will Laboratory Corporation of America Holdings' stock price be in 2017?

12 brokers have issued 1-year target prices for Laboratory Corporation of America Holdings' shares. Their forecasts range from $138.00 to $182.00. On average, they expect Laboratory Corporation of America Holdings' stock price to reach $156.64 in the next year. View Analyst Ratings for Laboratory Corporation of America Holdings.

What are analysts saying about Laboratory Corporation of America Holdings stock?

Here are some recent quotes from research analysts about Laboratory Corporation of America Holdings stock:

  • 1. According to Zacks Investment Research, "In majority of the last three months, LabCorp traded above the Zacks categorized Medical Dental Supplies industry. The company’s fourth-quarter report was impressive. Organic growth remained strong on introduction of new tests to existing and new customers. While the acquisition of Sequenom was a drag on fourth quarter earnings, we believe, down-the-line, the buyout will significantly boost LabCorp's women's health test menu. Additionally, LabCorp’s proposed acquisition of Mount Sinai’s Clinical Outreach Laboratories is also encouraging.On the flip side, unfavorable foreign exchange continues to be a dampener. Intense competition from several commercial laboratories and hospitals is a major headwind. Management’s mixed 2017 guidance also keeps us on the sidelines." (4/19/2017)
  • 2. Canaccord Genuity analysts commented, "LH bounced back from an underwhelming Q3 with a good Q4 that beat our/consensus estimates on the top and bottom lines. The 2017 guide is what we expected and we believe sets an appropriate bar for the company to execute against. LH spent a good portion of time on its call (in the Q&A) defending its strategic planning and responded to questions about its reported interest (Reuters) to acquire NC-based CRO Pharmaceutical Product Development (PPD) for ~$8 billion. While on one hand the deal would make sense to bolster its Covance business, our sense from investors is that most would prefer to see LH return more of its capital to shareholders in the form of share repurchases, which LH re-initiated in Q4. Regardless, we think the stock is cheap and it remains one of our five top picks for 2017 as we expect "mean-reverted" multiple expansion and another solid year of FCF (~$975M, or $9.43/sh.) and strong capital deployment. BUY. We raise our estimates and PT to $150 from $140." (2/17/2017)
  • 3. Mizuho analysts commented, "We are raising our price target to $139 ($135 previously) post 4Q on betterthan-expected cash flow guidance. We are maintaining our 2017E and 2018E adjusted EPS estimates of $9.65 and $10.32, respectively. LH reported a good 4Q and initial 2017 guidance despite some noise. The company also noted a more conservative approach to its CRO metrics, which we view favorably." (2/17/2017)

Who are some of Laboratory Corporation of America Holdings' key competitors?

Who are Laboratory Corporation of America Holdings' key executives?

Laboratory Corporation of America Holdings' management team includes the folowing people:

  • David P. King, Chairman of the Board, President, Chief Executive Officer
  • Glenn A. Eisenberg, Chief Financial Officer, Executive Vice President
  • John D. Ratliff, Chief Executive Officer - Covance Drug Development
  • Lisa J. Uthgenannt, Chief Human Resource Officer
  • Edward T. Dodson, Senior Vice President, Chief Accounting Officer, Principal Accounting Officer
  • Lance V. Berberian, Senior Vice President, Chief Information Officer
  • F. Samuel Eberts III, Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
  • Robert E. Mittelstaedt Jr., Lead Independent Director
  • Kerrii B. Anderson, Independent Director
  • Jean-Luc Belingard, Independent Director

Who owns Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Beck Mack & Oliver LLC (0.52%), APG Asset Management N.V. (0.41%), Meag Munich Ergo Kapitalanlagegesellschaft MBH (0.33%), Bank of Montreal Can (0.29%), AMI Asset Management Corp (0.25%) and Stack Financial Management Inc (0.17%). Company insiders that own Laboratory Corporation of America Holdings stock include David P King, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corporation of America Holdings.

Who sold Laboratory Corporation of America Holdings stock? Who is selling Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock was sold by a variety of institutional investors in the last quarter, including Boston Advisors LLC, DnB Asset Management AS, Chevy Chase Trust Holdings Inc., Affinity Investment Advisors LLC, AMI Asset Management Corp, Ipswich Investment Management Co. Inc., Exxonmobil Investment Management Inc. TX and Bartlett & Co. LLC. Company insiders that have sold Laboratory Corporation of America Holdings stock in the last year include Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corporation of America Holdings.

Who bought Laboratory Corporation of America Holdings stock? Who is buying Laboratory Corporation of America Holdings stock?

Laboratory Corporation of America Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Bank of Montreal Can, APG Asset Management N.V., Highland Capital Management LLC, Mn Services Vermogensbeheer B.V., Beck Mack & Oliver LLC, Country Club Trust Company n.a. and Aperio Group LLC. View Insider Buying and Selling for Laboratory Corporation of America Holdings.

How do I buy Laboratory Corporation of America Holdings stock?

Shares of Laboratory Corporation of America Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corporation of America Holdings' stock price today?

One share of Laboratory Corporation of America Holdings stock can currently be purchased for approximately $161.17.


MarketBeat Community Rating for Laboratory Corporation of America Holdings (NYSE LH)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  263 (Vote Outperform)
Underperform Votes:  328 (Vote Underperform)
Total Votes:  591
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corporation of America Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Laboratory Corporation of America Holdings (NYSE:LH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.58)
Consensus Price Target: $156.64 (2.81% downside)

Analysts' Ratings History for Laboratory Corporation of America Holdings (NYSE:LH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017Barclays PLCReiterated RatingOverweight$175.00 -> $182.00LowView Rating Details
7/13/2017Credit Suisse GroupDowngradeHold$146.00LowView Rating Details
4/28/2017Jefferies Group LLCLower Price TargetHold$159.00 -> $157.00LowView Rating Details
2/17/2017Canaccord GenuityBoost Price TargetBuy$140.00 -> $150.00N/AView Rating Details
2/17/2017MizuhoBoost Price TargetNeutral$135.00 -> $139.00N/AView Rating Details
2/6/2017Robert W. BairdDowngradeOutperform -> Neutral$138.00N/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$170.00N/AView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$156.00N/AView Rating Details
8/16/2016KeyCorpBoost Price TargetOverweight$143.00 -> $150.00N/AView Rating Details
7/28/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
7/27/2016Evercore ISIBoost Price TargetBuy$147.00 -> $155.00N/AView Rating Details
5/2/2016Morgan StanleyReiterated RatingBuyN/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$119.00N/AView Rating Details
3/4/2016William BlairReiterated RatingOutperformN/AView Rating Details
2/19/2016Royal Bank Of CanadaLower Price TargetSector Perform$135.00 -> $130.00N/AView Rating Details
2/4/2016Raymond James Financial, Inc.Lower Price TargetOutperform$145.00 -> $135.00N/AView Rating Details
12/17/2015Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 7/26/2015 forward)

Earnings

Earnings History for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Earnings History by Quarter for Laboratory Corporation of America Holdings (NYSE LH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017Q2 2017$2.40$2.47$2.47 billion$2.50 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.41 billion$2.41 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.49 billion$1.51 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Laboratory Corporation of America Holdings (NYSE:LH)
2017 EPS Consensus Estimate: $9.47
2018 EPS Consensus Estimate: $10.36
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.16$2.26$2.22
Q2 20175$2.41$2.50$2.46
Q3 20175$2.40$2.46$2.43
Q4 20175$2.30$2.43$2.37
Q1 20183$2.32$2.42$2.37
Q2 20183$2.64$2.77$2.69
Q3 20183$2.65$2.75$2.70
Q4 20183$2.57$2.68$2.61
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corporation of America Holdings (NYSE:LH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 91.28%
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Insider Trades by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.92View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.48View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.00View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.00View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.00View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.00View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.80View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.64View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.15View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.92View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.88View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.76View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.04View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.40View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.10View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.35View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.04View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.75View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.10View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.00View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.52View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.56View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.20View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.67View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.60View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.00View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.00View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.00View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.00View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.94View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Laboratory Corporation of America Holdings (NYSE:LH)
Latest Headlines for Laboratory Corporation of America Holdings (NYSE:LH)
Source:
DateHeadline
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 26 at 3:46 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Issues FY17 Earnings Guidance
www.americanbankingnews.com - July 26 at 10:50 AM
finance.yahoo.com logoLabCorp Introduces New ADAMTS13 Test for Rare Life-Threatening Blood Clot Disorder
finance.yahoo.com - July 20 at 12:17 AM
finance.yahoo.com logoLabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
finance.yahoo.com - July 18 at 4:38 PM
americanbankingnews.com logoBarclays PLC Reaffirms "Overweight" Rating for Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - July 17 at 10:20 PM
americanbankingnews.com logo$2.47 Billion in Sales Expected for Laboratory Corporation of America Holdings (NYSE:LH) This Quarter
www.americanbankingnews.com - July 15 at 8:19 AM
americanbankingnews.com logo$2.38 Earnings Per Share Expected for Laboratory Corporation of America Holdings (LH) This Quarter
www.americanbankingnews.com - July 13 at 2:16 PM
seekingalpha.com logoLaboratory Corporation of America Holdings (LH)
seekingalpha.com - July 13 at 6:24 AM
finance.yahoo.com logoLabCorp and Novant Health Extend Laboratory Services Agreement
finance.yahoo.com - July 12 at 2:16 AM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - July 4 at 10:26 AM
bizjournals.com logoLaboratory Corporation of America Holdings CEO David King chats ... - Triad Business Journal
www.bizjournals.com - June 30 at 11:33 PM
finance.yahoo.com logoWalgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores
finance.yahoo.com - June 30 at 1:04 AM
americanbankingnews.com logoBidaskClub Upgrades Laboratory Corporation of America Holdings (LH) to "Strong-Buy"
www.americanbankingnews.com - June 28 at 6:14 PM
nasdaq.com logoCommit To Buy Laboratory Corporation of America Holdings At $140, Earn 4.3% Annualized Using Options
www.nasdaq.com - June 27 at 6:27 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Cut to "Overweight" at KeyCorp
www.americanbankingnews.com - June 26 at 10:44 PM
finance.yahoo.com logoHealth-Care Stocks Get a Boost From Senate Bill Rollout
finance.yahoo.com - June 22 at 12:33 PM
americanbankingnews.com logoAnalyzing Select Medical Holdings Corporation (SEM) and Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - June 21 at 12:10 PM
americanbankingnews.com logo$2.46 Billion in Sales Expected for Laboratory Corporation of America Holdings (LH) This Quarter
www.americanbankingnews.com - June 21 at 9:54 AM
prnewswire.com logoMedical Laboratories Stock Performance Review -- VWR Corp., Quest Diagnostics, Laboratory Corp., and PerkinElmer - PR Newswire (press release)
www.prnewswire.com - June 20 at 3:49 PM
americanbankingnews.com logo Analysts Expect Laboratory Corporation of America Holdings (LH) to Post $2.39 EPS
www.americanbankingnews.com - June 19 at 2:08 PM
americanbankingnews.com logoLaboratory Corporation of America Holdings (LH) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - June 17 at 5:26 PM
finance.yahoo.com logoETFs with exposure to Laboratory Corp. of America Holdings : June 15, 2017
finance.yahoo.com - June 16 at 7:19 AM
americanbankingnews.com logoComparing HealthSouth Corporation (HLS) & Laboratory Corporation of America Holdings (LH)
www.americanbankingnews.com - June 15 at 8:44 PM
finance.yahoo.com logoCovance Opens State-of-the-Art Laboratory for Companion Diagnostics
finance.yahoo.com - June 14 at 10:51 AM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : June 14, 2017
finance.yahoo.com - June 14 at 10:51 AM
bizjournals.com logoLabCorp asks for dismissal of class-action lawsuit claiming it overcharges patients - Charlotte Business Journal
www.bizjournals.com - June 13 at 11:02 PM
finance.yahoo.com logoLabCorp asks for dismissal of class-action lawsuit claiming it overcharges patients
finance.yahoo.com - June 12 at 3:34 PM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Downgraded to Hold at BidAskClub
www.americanbankingnews.com - June 10 at 8:06 AM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 9 at 9:52 AM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Downgraded by ValuEngine
www.americanbankingnews.com - June 3 at 3:50 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bearish Manner : LH-US : May 29, 2017
finance.yahoo.com - May 29 at 9:16 AM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Rating Reiterated by Credit Suisse Group AG
www.americanbankingnews.com - May 28 at 11:30 AM
finance.yahoo.com logoETFs with exposure to Laboratory Corp. of America Holdings : May 26, 2017
finance.yahoo.com - May 26 at 7:05 PM
americanbankingnews.com logo$2.48 Billion in Sales Expected for Laboratory Corp. of America Holdings (LH) This Quarter
www.americanbankingnews.com - May 26 at 5:38 PM
americanbankingnews.com logo Analysts Expect Laboratory Corp. of America Holdings (LH) Will Post Quarterly Sales of $2.48 Billion
www.americanbankingnews.com - May 26 at 5:18 PM
americanbankingnews.com logo Analysts Anticipate Laboratory Corp. of America Holdings (LH) to Announce $2.42 EPS
www.americanbankingnews.com - May 24 at 1:28 PM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) SVP Sells $505,241.92 in Stock
www.americanbankingnews.com - May 24 at 1:23 PM
finance.yahoo.com logoLabCorp Exclusively Launches Sera Prognostics’ PreTRM Test to Assess for Risk of Preterm Birth
finance.yahoo.com - May 23 at 10:44 AM
nasdaq.com logoVeritas Investment Management (UK) Ltd Buys Franco-Nevada Corp, Laboratory Corp of America ...
www.nasdaq.com - May 16 at 10:45 AM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Director Jean-Luc Belingard Sells 992 Shares
www.americanbankingnews.com - May 11 at 10:38 AM
americanbankingnews.com logoCraig Hallum Equities Analysts Cut Earnings Estimates for Laboratory Corp. of America Holdings (LH)
www.americanbankingnews.com - May 10 at 8:26 AM
finance.yahoo.com logoLabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
finance.yahoo.com - May 9 at 12:01 PM
americanbankingnews.com logoSomewhat Positive Press Coverage Likely to Affect Laboratory Corp. of America Holdings (LH) Share Price
www.americanbankingnews.com - May 9 at 12:50 AM
finance.yahoo.com logoLabCorp completes acquisition of 1,600-employee Washington firm
finance.yahoo.com - May 5 at 6:58 AM
finance.yahoo.com logoLabCorp Completes Acquisition of Pathology Associates Medical Laboratories
finance.yahoo.com - May 4 at 6:25 PM
finance.yahoo.com logoLabCorp to Webcast Its Annual Meeting of Shareholders
finance.yahoo.com - May 4 at 11:57 AM
finance.yahoo.com logoLabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio with Addition of New Panels and New Genes That Can Be Assessed
finance.yahoo.com - May 3 at 5:23 PM
finance.yahoo.com logoETFs with exposure to Laboratory Corp. of America Holdings : May 3, 2017
finance.yahoo.com - May 3 at 5:23 PM
americanbankingnews.com logoLaboratory Corp. of America Holdings (LH) Expected to Post Quarterly Sales of $2.48 Billion
www.americanbankingnews.com - May 3 at 3:16 PM
finance.yahoo.com logoLaboratory Corp. of America Holdings :LH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 2, 2017
finance.yahoo.com - May 2 at 7:36 PM

Social

Chart

Laboratory Corporation of America Holdings (LH) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff